Open-Label, Safety and Tolerability Extension Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS) (CL211)
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
This is an open-label, multi-center study designed to extend the evaluation of the safety,
tolerability, and clinical effects of oral administration of KNS-760704 in patients with ALS.